Skip to main content

Table 3 Immunohistochemistry results of CK19 and Galectin-3 in papillary thyroid carcinoma (PTC) with or without lymphatic metastasis and other nonmalignant thyroid lesions

From: Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China

    nodular goiter
n = 97
Follicular adenoma
N = 54
PTC1
N = 248
PTC2
N = 193
CK19 + Female 21(21.65) 10(18.52) 202(81.45) 121(62.69)
   Male 5(5.15) 3(5.56) 44(17.75) 58(30.05)
  - Female 52(53.61) 30(55.56) 0(0.00) 8(4.15)
   Male 19(19.59) 11(20.36) 2(0.80) 6(3.11)
Galectin + Female 37(38.15) 19(35.19) 196(79.03) 122(63.21)
   Male 14(14.43) 7(12.96) 45(18.14) 64(33.16)
  - Female 36(37.11) 21(38.89) 6(2.43) 7(3.63)
   Male 10(10.31) 7(12.96) 1(0.40) 0(0.00)
  1. PTC1: papillary thyroid carcinoma (PTC) without lymphatic metastasis
  2. PTC2: papillary thyroid carcinoma (PTC) with lymphatic metastasis